Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
American Journal of Physiology. Endocrinology and Metabolism|May 25, 2012
Differential effects of oxyntomodulin and GLP-1 on glucose metabolismXiaobing Du, Jennifer R Kosinski, Julie Lao, et al.Bioorganic & Medicinal Chemistry Letters|January 18, 2006
1-Phenyl-8-azabicyclo[3.2.1]octane ethers: a novel series of neurokinin (NK1) antagonistsIan T Huscroft, Emma J Carlson, Gary G Chicchi, et al.Gene|October 18, 2002
Identification, localization and receptor characterization of novel mammalian substance P-like peptidesMarc M Kurtz, Ruiping Wang, Michelle K Clements, et al.Bioorganic & Medicinal Chemistry Letters|November 26, 2005
Synthesis and structure-activity relationships of 8-azabicyclo[3.2.1]octane benzylamine NK1 antagonistsChristopher G Thomson, Emma Carlson, Gary G Chicchi, et al.Journal of Neurochemistry|August 5, 2008
Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429Nicolas Singewald, Gary G Chicchi, Clemens C Thurner, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2007
Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonistsJonathan R Young, Ronsar Eid, Cherilyn Turner, et al.Bioorganic & Medicinal Chemistry Letters|April 1, 2006
NK1 antagonists based on seven membered lactam scaffoldsJason M Elliott, Emma J Carlson, Gary G Chicchi, et al.Obesity (Silver Spring, Md.)|March 17, 2012
The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulinJennifer R Kosinski, James Hubert, Paul E Carrington, et al.Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Spirocyclic NK(1) antagonists II: [4.5]-spiroethersBrian J Williams, Margaret A Cascieri, Gary G Chicchi, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Cyclopentane-based human NK1 antagonists. Part 1: discovery and initial SARPaul E Finke, Laura C Meurer, Dorothy A Levorse, et al.Pageof 4